Article Details
Retrieved on: 2021-06-04 14:26:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Vir Biotechnology Inc is now considered extended and out of buy range after clearing a 16.60 buy point in a first-stage consolidation. See if the stock ...
Article found on: www.investors.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here